$UCLE U.S. Nuclear Corp. is First to $7.4B PFAS Detection Market
https://richardacavalli.wixsite.com/greenplan...fas-market
The EPA recently passed regulations that will require 148,000 water providers to test and treat their water for PFAS which is believed to be responsible for widespread cancers, birth defects, high cholesterol and more.
Currently, there are no devices available for sale for this testing and all water providers must send in samples to the big labs with high costs and long times for results that can take several weeks.
The new regulations create what is projected to be a $7.4B need for portable and accurate, and fast PFAS detection devices in the United States and probably double that for the rest of the world.
U.S. Nuclear Corp., a long-standing company known for its’ expertise in radiation measurement recently announced their new portable PFAS detection and monitoring device that meets government requirements.
Each unit sells for about $50,000 and demand from 148,000 municipal water districts and industrial manufacturers is projected to be $7.4B for the United States alone
U.S. Nuclear Corp trades at 8 cents per share with a very small market cap of about $3.15 million.
The EPA has taken strong action designating two widely used PFAS as hazardous substances under the Superfund law, improving transparency and accountability to clean up PFAS contamination in communities. The U.S. Environmental Protection Agency (EPA) is taking another step in its efforts to protect people from the health risks posed by exposure to “forever chemicals” in communities across the country.
Almost a year ago, US Nuclear Corp. (UCLE: OTCQB) revealed in a press release that they were offering portable and benchtop PFAS detection devices that are capable of determining extremely minute amounts of PFAS, PFOS and PFOA’s down to 1 part per trillion within less than 2 minutes. The units are expected to be sold for $50,000 per unit and there are now about 148,000 municipal water districts that will be required to test their water within a relatively short timeline.
Our research indicates that US Nuclear’s PFAS detection system is unique to the market.
Exposure to per-and polyfluoroalkyl substances (PFAS) has been linked to cancers, impacts to the liver and heart, and immune and developmental damage to infants and children. This final rule will designate two widely used PFAS chemicals, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), also known as Superfund, and will help ensure that polluters pay to clean up their contamination.
This final action will address PFOA and PFOS contamination by enabling detection and cleanup of these harmful chemicals and ensuring that leaks, spills, and other releases are reported. This action builds on the recently finalized standards to protect people and communities from PFAS contamination in drinking water and represents the latest step the Biden-Harris Administration is taking to protect public health and welfare and the environment under EPA’s PFAS Strategic Roadmap and to prevent cancer before it starts through the Biden Cancer Moonshot.
In addition to the final rule, EPA is issuing a separate CERCLA enforcement discretion policy that makes clear that EPA will focus enforcement on parties who significantly contributed to the release of PFAS chemicals into the environment, including parties that have manufactured PFAS or used PFAS in the manufacturing process, federal facilities, and other industrial parties.
Conclusion
US Nuclear Corp. is a unique long-standing company that got its start from the Manhattan Project, the development of the Atomic Bomb which the recent movie Oppenheimer was all about. Since then, US Nuclear Corp has developed a wide array of sensitive detection instruments for government and research lab use and is now branching out to broader markets with large unmet needs such as PFAS detectors that are capable of measuring PFAS in less than 4 parts per trillion which is like a grain of sand in an Olympic sized swimming pool.
US Nuclear also owns an interest and is partnered with the leading fusion energy and radioisotope developers, MIFTI and MIFTEC and an advanced materials company called Grapheton that is making breakthrough medical devices that can be implanted in the body that have greatly extended life spans and game changing advantages over the competition.
With strong and well-timed growth potential and a total market cap of about $3.15 million, and shares trading close to historic lows, US Nuclear Corp appears to be an outstanding investment consideration.
https://richardacavalli.wixsite.com/greenplan...fas-market
The EPA recently passed regulations that will require 148,000 water providers to test and treat their water for PFAS which is believed to be responsible for widespread cancers, birth defects, high cholesterol and more.
Currently, there are no devices available for sale for this testing and all water providers must send in samples to the big labs with high costs and long times for results that can take several weeks.
The new regulations create what is projected to be a $7.4B need for portable and accurate, and fast PFAS detection devices in the United States and probably double that for the rest of the world.
U.S. Nuclear Corp., a long-standing company known for its’ expertise in radiation measurement recently announced their new portable PFAS detection and monitoring device that meets government requirements.
Each unit sells for about $50,000 and demand from 148,000 municipal water districts and industrial manufacturers is projected to be $7.4B for the United States alone
U.S. Nuclear Corp trades at 8 cents per share with a very small market cap of about $3.15 million.
The EPA has taken strong action designating two widely used PFAS as hazardous substances under the Superfund law, improving transparency and accountability to clean up PFAS contamination in communities. The U.S. Environmental Protection Agency (EPA) is taking another step in its efforts to protect people from the health risks posed by exposure to “forever chemicals” in communities across the country.
Almost a year ago, US Nuclear Corp. (UCLE: OTCQB) revealed in a press release that they were offering portable and benchtop PFAS detection devices that are capable of determining extremely minute amounts of PFAS, PFOS and PFOA’s down to 1 part per trillion within less than 2 minutes. The units are expected to be sold for $50,000 per unit and there are now about 148,000 municipal water districts that will be required to test their water within a relatively short timeline.
Our research indicates that US Nuclear’s PFAS detection system is unique to the market.
Exposure to per-and polyfluoroalkyl substances (PFAS) has been linked to cancers, impacts to the liver and heart, and immune and developmental damage to infants and children. This final rule will designate two widely used PFAS chemicals, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), also known as Superfund, and will help ensure that polluters pay to clean up their contamination.
This final action will address PFOA and PFOS contamination by enabling detection and cleanup of these harmful chemicals and ensuring that leaks, spills, and other releases are reported. This action builds on the recently finalized standards to protect people and communities from PFAS contamination in drinking water and represents the latest step the Biden-Harris Administration is taking to protect public health and welfare and the environment under EPA’s PFAS Strategic Roadmap and to prevent cancer before it starts through the Biden Cancer Moonshot.
In addition to the final rule, EPA is issuing a separate CERCLA enforcement discretion policy that makes clear that EPA will focus enforcement on parties who significantly contributed to the release of PFAS chemicals into the environment, including parties that have manufactured PFAS or used PFAS in the manufacturing process, federal facilities, and other industrial parties.
Conclusion
US Nuclear Corp. is a unique long-standing company that got its start from the Manhattan Project, the development of the Atomic Bomb which the recent movie Oppenheimer was all about. Since then, US Nuclear Corp has developed a wide array of sensitive detection instruments for government and research lab use and is now branching out to broader markets with large unmet needs such as PFAS detectors that are capable of measuring PFAS in less than 4 parts per trillion which is like a grain of sand in an Olympic sized swimming pool.
US Nuclear also owns an interest and is partnered with the leading fusion energy and radioisotope developers, MIFTI and MIFTEC and an advanced materials company called Grapheton that is making breakthrough medical devices that can be implanted in the body that have greatly extended life spans and game changing advantages over the competition.
With strong and well-timed growth potential and a total market cap of about $3.15 million, and shares trading close to historic lows, US Nuclear Corp appears to be an outstanding investment consideration.
